DARE Daré Bioscience Quarterly EPS earnings growth

Corporate emblem and logo of Dare Bioscience Inc. (DARE)

The non-cyclical nature of women's health biopharmaceuticals makes the quarterly earnings per share chart dependent on scientific trials rather than the economy. Dare Bioscience, Inc. (DARE) strengthens its financial foundation through an ecosystem of unique therapeutic standards and the global scaling of FDA-approved drugs via partnerships. The current 55.70 indicator determines the metric's magnitude, visualizing the business's daily operational yield and eliminating information gaps between reports.

darebioscience.com (DARE) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/12/2026

DARE (Daré Bioscience, Inc.): analytical breakdowns and indicator data

- market value and analyst target forecast:
Price Chart Daré Bioscience|DARE - Consensus Target
- market capitalization data:
Market Capitalization Dare Bioscience Inc.|DARE - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Daré Bioscience|DARE - Accounting Capitalization|Market Capitalization to Book Value Ratio darebioscience.com|DARE - Total Business Assets
- company liabilities and liquidity data:
Total Debt to Capital Dare Bioscience, Inc.|DARE - Long-Term Debt to Capital|Short-Term Debt to Equity Dare Bioscience, Inc.|DARE - Aggregate Debt Obligations|Debts to Book Capitalization Dare Bioscience Inc.|DARE - Long-Term Debt|Company Current Liabilities Daré Bioscience|Quick Ratio darebioscience.com
- earnings and market multiples details:
DARE - Company Net Income|Projected Future Earnings Dare Bioscience, Inc.|DARE - Business Payback Period|Future Price to Earnings Dare Bioscience Inc.|DARE - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dare Bioscience Inc.|DARE - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Daré Bioscience|DARE - Net earnings per share for the last 12 months|Quarterly EPS earnings growth darebioscience.com|DARE - Expected net earnings per share growth this year|Earnings growth forecast for next year Dare Bioscience, Inc.
Summary company analytics:Daré Bioscience - DARE
Flagship merchandise of Dare Bioscience, Inc.

This indicator measures the percentage change in net earnings per share per quarter, allowing investors to track profitability trends between official reports. Analyzing the quarterly EPS growth trajectory for Dare Bioscience, Inc. (DARE) helps assess how investments in innovative contraception and women's health convert into real capital, confirming the effectiveness of the company's business model.

Analysis of competing companies

Organon (OGN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months TherapeuticsMD|PTN (Palatin) - Quarterly EPS earnings growth